Biomarkers of potential harm in people switching from smoking tobacco to exclusive e-cigarette use, dual use, or abstinence: secondary analysis of Cochrane systematic review of trials of e-cigarettes for smoking cessation by Hartmann-Boyce, J, Butler, AR, Theodoulou, A, Onakpoya, IJ, Hajek, P, Bullen, C, Rigotti, NA, Lindson, N

Index kesahan kandungan dan kesahan muka : M-socrates-s (Malay version of the stages of change readiness and treatment eagerness scale for smoking cessation) dan M-SSE (Malay version of smoking self efficacy) by Mohd Haazik Mohamed, Wanda Kiyah George Albert, Voo, Su Kiong Peter, Ismail Maakip, Fredie Robinson

“…Oleh yang demikian kajian ini dijalankan bagi mengenalpasti nilai index kesahan kandungan dan keshan muka bagi alat ujian M-SOCRATES-S (Malay Version of the Stages of Change Readiness and Treatment Eagerness Scale for Smoking Cessation) dan M-SSE (Malay Version of Smoking Self Efficacy). …”
Get full text

A Qualitative Exploration Of Perceptions Among Patients And Health Care Professionals Towards Smoking Cessation Treatment Failure And Process And Economic Outcome Assessment Of Pharmacist Managed Quit Smoking Clinic In The State Of Malacca, Malaysia by Lee, Mei Lin

Get full text

ANALISIS FAKTOR-FAKTOR YANG MEMPENGARUHI NIAT PASIEN POLIKLINIK PENYAKIT DALAM UNTUK MEMANFAATKAN KLINIK BERHENTI MEROKOK DI RUMAH SAKIT UMUM DAERAH KOTA YOGYAKARTA by , Wina Widiastuti, , Dra. Yayi Suryo Prabandari, M.Si., Ph.D

“…An effort relevant with strategy 3 of MPOWER is helping someone to quit smoking through the provision of smoking cessation clinic. In 2009 there were 18 smoking cessation clinics spread all over health services and government institutions. …”

Counselling patients about behaviour change: the challenge of talking about diet. by Phillips, K, Wood, F, Spanou, C, Kinnersley, P, Simpson, SA, Butler, C

“…The content of healthy eating consultations was contrasted with that given for smoking cessation. RESULTS: There was a lack of consistency and clarity when clinicians discussed healthy eating compared with smoking; in smoking cessation consultations, the content was clearer to both the clinician and patient. …”

Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial by Nichols, J, Grob, P, Kite, W, Williams, P, De Lusignan, S

“…Each group had 8 weeks of weekly smoking cessation sessions involving group therapy and advice on smoking cessation pharmacotherapy and follow-up at 6 months. …”

Managing vascular risk factors among obese quitters with diabetes: how intensive lifestyle intervention and novel pharmacotherapy can work in concert by Kar, D, Seidu, S, Davies, M, Khunti, K

“…Weight loss and smoking cessation are key interventions advocated for the management of diabetes in almost all the guidelines across the globe. …”

Genetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer risk by Nichols, JAA, Grob, P, de Lusignan, S, Kite, W, Williams, P

“…<p><strong>Background:&nbsp;</strong>A gene-based estimate of lung cancer risk in smokers has been shown to act as a smoking cessation motivator in hospital recruited subjects. …”

Adverse reaction to nicotine gum in a poor metaboliser by Robson, N.Z., Bond, A.J., Wolff, K.

“…Background: NG is prescribed in smoking cessation programs to help individuals stop smoking. …”

Interventions to reduce tobacco use in people experiencing homelessness by Vijayaraghavan, M, Elser, H, Frazer, K, Lindson, N, Apollonio, D

“…We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for smoking cessation for each study where possible. We grouped eligible studies according to the type of comparison (contingent reinforcement in addition to usual smoking cessation care; more versus less intensive smoking cessation interventions; and multi‐issue support versus smoking cessation support only), and carried out meta‐analyses where appropriate, using a Mantel‐Haenszel random‐effects model. …”

Vaping for weight control: Findings from a qualitative study by Dobbie, F, Uny, I, Jackson, SE, Brown, J, Aveyard, P, Bauld, L

“…Nicotine in e-cigarettes, as well as vaping behaviour, may support smoking cessation by reducing weight gain. This study explored the factors that influence attitudes towards, and awareness of, e-cigarettes and weight control post smoking cessation.…”

The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: secondary analysis of a randomized controlled trial in primary care by Hollands, GJ, Sutton, S, Aveyard, P

“…<p><strong>Introduction:</strong> Nicotine replacement therapy (NRT) is effective for smoking cessation, but the optimal method of using NRT to maximize benefit is unclear. …”

Cytisine and the failure to market and regulate for human health. by Aveyard, P, West, R

“…<p>BACKGROUND A recent rigorous study has shown that cytisine, a low-cost drug, is effective for smoking cessation. A number of earlier studies exist, mostly from former communist countries where cytisine has been used since the 1960s. …”

Differences in longer-term smoking abstinence after treatment by specialist or nonspecialist advisors: secondary analysis of data from a relapse prevention trial by Song, F, Maskrey, V, Blyth, A, Brown, T, Barton, G, Aveyard, P, Notley, C, Holland, R, Bachmann, M, Sutton, S, Brandon, T

“…Smokers receiving support in specialist centers tend to have a higher short-term quit rate, compared with those receiving support in other settings from professionals for whom smoking cessation is only a part of their work. We investigated the difference in longer-term abstinence after short-term smoking cessation treatment from specialist and nonspecialist smoking cessation services.We conducted a secondary analysis of data from a randomized controlled trial of self-help booklets for the prevention of smoking relapse. …”

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. by David, S, Munafò, MR, Murphy, M, Walton, RT, Johnstone, E

“…In summary, despite the theoretically important contribution of serotonin neurotransmission to smoking cessation, the serotonin transporter gene was not associated with treatment response to nicotine patch for smoking cessation in this primary care-based trial.…”

Pooling data for number needed to treat: no problems for apples by Moore, R, Gavaghan, D, Edwards, J, Wiffen, P, McQuay, H

“…OBJECTIVE: To consider the problem of the calculation of number needed to treat (NNT) derived from risk difference, odds ratio, and raw pooled events shown to give different results using data from a review of nursing interventions for smoking cessation. DISCUSSION: A review of nursing interventions for smoking cessation from the Cochrane Library provided different v…”

Smokeless by Weng, Yayu

“…Smokeless will be a system that provides the smoker with motivation and restraint that they require through the tough journey of smoking cessation.…”
Get full text

Meditation-induced changes in high-frequency heart rate variability predict smoking outcomes by Libby, D, Worhunsky, P, Pilver, C, al., E

“…Conclusion: Acute changes in HF-HRV in response to meditation may be a useful tool to predict smoking cessation treatment response..…”

Assessment of smoking care by stroke specialists in patients with recent TIA and minor stroke: an international prospective registry-based cohort study by Lavallee, P, Charles, H, Labreuche, J, Albers, GW, Caplan, L, Donnan, GA, Ferro, JM, Hennerici, MG, Molina, CA, Rothwell, P, Steg, G, Touboul, P, Uchiyama, S, Vicaut, E, Wong, LKS, Amarenco, P

“…Outcomes: Tobacco counselling and smoking-cessation pharmacotherapy use in smoking patients were reported at discharge. …”

Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. by Mocking, R, Patrick Pflanz, C, Pringle, A, Parsons, E, McTavish, S, Cowen, P, Harmer, C

“…Varenicline is an effective and increasingly prescribed drug for smoking cessation, but has been associated with depressive symptoms and suicidal behavior. …”